Kayentis

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

News

MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.